secwatch / observer
8-K filed June 2, 2026, 6:31 AM ET ticker OSCR CIK 0001568651
leadership confidence high sentiment neutral materiality 0.50

Oscar Health Co-Founder Schlosser transitions from CTO to Advisor to CEO

Oscar Health, Inc.

item 5.02

Machine-readable event card

schema_version
secwatch.filing_event.v1
accession
0001568651-26-000048
form_type
8-K
ticker
OSCR
cik
0001568651
company_name
Oscar Health, Inc.
filed_at
2026-06-02T10:31:58+00:00
discovered_at
2026-06-02T10:35:00.310077+00:00
generated_at
2026-06-02T10:35:10.123157+00:00
sec_items
["5.02"]
event_type
leadership
sentiment
neutral
materiality_score
0.5
calibrated_materiality_score
0.5
confidence
high
secwatch_canonical_url
https://secwatch.observer/filing/0001568651-26-000048
json_url
https://secwatch.observer/filing/0001568651-26-000048.json
markdown_url
https://secwatch.observer/filing/0001568651-26-000048.md
text_url
https://secwatch.observer/filing/0001568651-26-000048.txt
edgar_index_url
https://www.sec.gov/Archives/edgar/data/1568651/000156865126000048/0001568651-26-000048-index.htm
edgar_primary_document_url
https://www.sec.gov/Archives/edgar/data/1568651/000156865126000048/oscr-20260529.htm
generated_by_model
deepseek-v4-flash:cloud@v2
review_status
machine_generated
human_reviewed
false
corrected
false
correction_note
null
correction_timestamp
null
superseded_by
null
JSON Markdown Plain text

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Role change

Mario Schlosser

Co-Founder & Advisor to the CEO
OSCR · Oscar Health, Inc.
Effective
2026-06-01
Filed
June 2, 2026, 6:31 AM ET
Mr. Schlosser’s transition from President of Technology and Chief Technology Officer of the Company to Co-Founder & Advisor to the CEO.

Source-grounded claims

dbff2a1f63

Mario Schlosser changed role as Co-Founder & Advisor to the CEO at Oscar Health, Inc..

Mr. Schlosser’s transition from President of Technology and Chief Technology Officer of the Company to Co-Founder & Advisor to the CEO.

SEC 8-K Item 5.02 confidence 0.95 SEC evidence

Comparable filings

Cornerstone Building Brands, Inc.

Cornerstone Building Brands names Richard Dirkson as Corporate Controller; CAO departs

Cornerstone Building Brands, Inc. June 2, 2026, 10:32 AM ET leadership Items 5.02, 5.07

same fact type: executive_change same SEC item: 5.02 same event type: leadership similar materiality

This filing

Mr. Schlosser’s transition from President of Technology and Chief Technology Officer of the Company to Co-Founder & Advisor to the CEO.

Comparable filing

On May 27, 2026, the Company appointed Richard Dirkson as Senior Vice President, Corporate Controller (principal accounting officer) of the Company, effective May 28, 2026.

Filing page SEC filing

ALH

COO International Jan Vleugels to retire Sept 30; Bob Calver named successor; new VP IR

Alliance Laundry Holdings Inc. June 2, 2026, 9:16 AM ET leadership Items 5.02, 7.01, 9.01

same fact type: executive_change same SEC item: 5.02 same event type: leadership similar materiality

This filing

Mr. Schlosser’s transition from President of Technology and Chief Technology Officer of the Company to Co-Founder & Advisor to the CEO.

Comparable filing

Mr. Jan Vleugals, Chief Operating Officer International of Alliance Laundry Holdings Inc. (the “Company”), provided notice of his decision to retire effective as of September 30, 2026

Filing page SEC filing

ONCY

Oncolytics appoints Steve Glover to board, promotes John McAdory to COO

ONCOLYTICS BIOTECH INC June 2, 2026, 9:02 AM ET leadership Items 5.02, 8.01, 9.01

same fact type: executive_change same SEC item: 5.02 same event type: leadership similar materiality

This filing

Mr. Schlosser’s transition from President of Technology and Chief Technology Officer of the Company to Co-Founder & Advisor to the CEO.

Comparable filing

appointed John McAdory as Chief Operating Officer of the Company

Filing page SEC filing

ACHV

Achieve Life Sciences appoints Jeff Farrow and Dr. Reid Waldman to Board

ACHIEVE LIFE SCIENCES, INC. June 2, 2026, 8:51 AM ET leadership Items 5.02

same fact type: executive_change same SEC item: 5.02 same event type: leadership similar materiality

This filing

Mr. Schlosser’s transition from President of Technology and Chief Technology Officer of the Company to Co-Founder & Advisor to the CEO.

Comparable filing

the Board of Directors (the “Board”) of Achieve Life Sciences, Inc. (the “Company”) appointed Jeff Farrow and Reid Waldman, M.D. (together, the “Incoming Directors”), as directors, effective as of such date.

Filing page SEC filing

PAGP

Plains GP Holdings announces CAO succession: Montgomery promoted, Herbold retiring

PLAINS GP HOLDINGS LP June 2, 2026, 6:05 AM ET leadership Items 5.02

same fact type: executive_change same SEC item: 5.02 same event type: leadership similar materiality

This filing

Mr. Schlosser’s transition from President of Technology and Chief Technology Officer of the Company to Co-Founder & Advisor to the CEO.

Comparable filing

effective September 1, 2026, Russ Montgomery will be promoted to the position of Vice President, Accounting and Chief Accounting Officer of Plains All American GP LLC, the general partner of PAA, and PAA GP Holdings LLC, the general partner of PAGP.

Filing page SEC filing

PAA

Plains All American announces CAO retirement and Montgomery promotion effective Sep 1, 2026

PLAINS ALL AMERICAN PIPELINE LP June 2, 2026, 6:03 AM ET leadership Items 5.02

same fact type: executive_change same SEC item: 5.02 same event type: leadership similar materiality

This filing

Mr. Schlosser’s transition from President of Technology and Chief Technology Officer of the Company to Co-Founder & Advisor to the CEO.

Comparable filing

Chris Herbold, who previously served as Senior Vice President, Finance and Chief Accounting Officer of PAA and PAGP, is retiring from the company on August 31, 2026.

Filing page SEC filing

AHCO

AdaptHealth amends 8-K to disclose COO Daniel McFadden's compensation: base salary raised to $550K, plus RSU grant

AdaptHealth Corp. June 1, 2026, 9:02 PM ET leadership Items 5.02, 9.01

same fact type: executive_change same SEC item: 5.02 same event type: leadership similar materiality

This filing

Mr. Schlosser’s transition from President of Technology and Chief Technology Officer of the Company to Co-Founder & Advisor to the CEO.

Comparable filing

the appointment of Daniel McFadden as Chief Operating Officer of the Company, effective as of May 4, 2026

Filing page SEC filing

HON

Honeywell appoints Jill Evanko to Board of Directors, effective June 1, 2026

HONEYWELL INTERNATIONAL INC June 1, 2026, 8:12 PM ET leadership Items 5.02, 7.01, 9.01

same fact type: executive_change same SEC item: 5.02 same event type: leadership similar materiality

This filing

Mr. Schlosser’s transition from President of Technology and Chief Technology Officer of the Company to Co-Founder & Advisor to the CEO.

Comparable filing

Ms. Jillian Evanko, 48, Chief Executive Officer of Duravant LLC, has been appointed to serve as an Independent Director on the Company’s Board of Directors and a member of the Audit Committee, in each case, effective June 1, 2026.

Filing page SEC filing

Source: SEC EDGAR
accession 0001568651-26-000048
view filing index on sec.gov
view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.